Skip to main content
. Author manuscript; available in PMC: 2017 Aug 17.
Published in final edited form as: J Endocrinol. 2007 May;193(2):225–233. doi: 10.1677/JOE-06-0138

Figure 5.

Figure 5

Relationships of tumour tissue levels of PNMT mRNA (A and B) or adrenaline (C and D) with NPY mRNA (A and C) or peptide (B and D). (●) Non-syndromic noradrenergic tumours; (■) non-syndromic adrenergic tumours; (○) VHL tumours; (□) MEN 2 tumours.